Benign separation process being advanced for pharmaceutical industry

Simple item page
dc.contributor.authorTrulove, Susanen
dc.coverage.spatialBlacksburg, Va.en
dc.date.accessioned2013-05-06T19:31:43Zen
dc.date.available2013-05-06T19:31:43Zen
dc.date.issued2005-03-16en
dc.description.abstractPharmaceutical companies perform many separations of molecules before they begin to synthesize the most ideal safe, pure, effective compound or sub-compound into a drug.en
dc.format.mimetypetext/htmlen
dc.identifier.urihttp://hdl.handle.net/10919/21678en
dc.publisherVirginia Tech. University Relationsen
dc.rightsIn Copyrighten
dc.rights.holderVirginia Tech. University Relationsen
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.titleBenign separation process being advanced for pharmaceutical industryen
dc.typePress releaseen
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Name:
2005-657.html
Size:
2.72 KB
Format:
Hypertext Markup Language
Download

Collections

Virginia Tech News